Why the study?
Are elevated plasma chemerin levels associated with impaired endothelial function and increased arterial stiffness in newly diagnosed essential hypertensive patients?
Are elevated plasma chemerin levels associated with impaired endothelial function and increased arterial stiffness in newly diagnosed essential hypertensive patients?
Elevated plasma chemerin levels are independently associated with impaired endothelial function and increased arterial stiffness in patients with newly diagnosed essential hypertension.
Chemerin associated with endothelial dysfunction, stiffness, and atherosclerosis in hypertension; leaves open biomarker or causal role.
OBJECTIVES: Chemerin is a new adipokine elevated in states of obesity and metabolic syndromes. In this study, we investigated the association of increased chemerin on endothelial function, arterial stiffness and early atherosclerosis in essential hypertensive patients. METHODS: Three hundred and sixty-seven newly diagnosed essential hypertensive patients were enrolled. Anthropometric measurements and plasma parameters were examined, including BMI, waist circumference, glucose, serum insulin, lipid profiles, chemerin, high-sensitivity C-reactive protein, tumor necrosis factor-α, and interleukin-4. Vascular health was assessed with brachial flow-mediated dilatation (FMD), brachial-ankle pulse wave velocity (baPWV), and carotid intima-media thickness (IMT). RESULTS: In hypertensive patients, plasma chemerin levels were higher in women than in men (P < 0.05). In univariate analysis, the plasma chemerin level was positively correlated with baPWV (men: r = 0.58, P < 0.01; women: r = 0.51, P < 0.01) and carotid IMT (men: r = 0.17, P = 0.01; women: r = 0.20, P = 0.01), and inversely correlated with FMD (men: r = -0.54, P < 0.01; women: r = -0.44, P < 0.01). The associations for FMD and baPWV, but not IMT, remained significant in multivariable models adjusted for age, sex, glucose homeostasis, lipid profiles, inflammation markers and adipokines. More importantly, logistic regression analysis revealed that high chemerin level was an independent predictor of impaired endothelial function (FMD odds ratio 1.58, 95% confidence interval 1.28-3.30, P = 0.03) and increased arterial stiffness (baPWV odds ratio 3.75, 95% confidence interval 1.36-5.28, P < 0.01), even after adjustment for metabolic variables, inflammatory markers and adipokines. CONCLUSION: Chemerin levels were independently associated with the index of arterial function and early atherosclerosis in essential hypertension.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: